Medical Services Completes Further Testing of Its VScan HIV Test Kit With Excellent Results
Posted on: Wednesday, 27 December 2006, 00:00 CST
EDMONTON, Alberta, Dec. 27 /PRNewswire-FirstCall/ -- Medical Services International Inc. (Pinksheets: MSITF) is pleased to announce that it has completed additional testing of its VScan HIV test kit with the National Institute For Communicable Diseases. The regulatory agency tested 500 VScan HIV test kits with the following test results: Sensitivity- 100%, Specificity- 100%. It is very rare for a test kit to test with such accuracy. The final report also refers to ease of performance with a rating of "very easy to use" and suitability for use rating as "very suitable." A report of this magnitude from an agency with the excellent reputation of the National Institute For Communicable Diseases confirms the reliability of the VScan HIV test kit.
This report once again demonstrates the accuracy of the VScan HIV test kit. The many excellent independent test results are now being included in new updated marketing brochures and will be included on the new website that is currently being constructed. It is felt that reports of this magnitude combined with additional approvals in more countries combined with the new website will significantly increase kit sales in 2007. The Company is looking forward to an exceptional new year.
About VScan
The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.
Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF." For further information, please contact Robert Talbot at (780) 430 6363 or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/.
NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies.
Medical Services International Inc.
CONTACT: Robert Talbot of Medical Services International Inc.,+1-780-430-6363
Web site: http://www.medicalservicesintl.com/http://www.minerva-biotech.com/
Source: PRNewswire-FirstCall
Related Articles
- Medical Services International Begins Shipping VScan TB Test Kits to South Africa
- Free Test Kits, Oil Tank Cleanup Services Available Until Sept. 8 in Counties Affected By June Floods
- Medical Services International to Begin Shipping VScan HIV Test Kits Into Europe
- Medical Services New Test Kit to Be Independently Tested for Market
- Medical Services VScan HIV Test Kit Used During LIVE Test on Television
- Medical Services to Supply VScan Test Kits to Hospitals
- Medical Services International to Supply VScan Test Kits for Private Testing
- FDA to Consider Approving Home Test Kit for HIV
- Medical Services Receives Regulatory Approval for Its VScan Tuberculosis (TB) Rapid Test Kit
 |
 |
User Comments (0)
RSS Feeds